Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Myriad Genetics Inc

(NASDAQ: MYGN)
Add to Portfolio
-0.53 (-3.46%)
as of Apr 7, 2020

Values in US Thousands
  06-2019 06-2018 06-2017 06-2016
Sales $ 851,100 $ 743,700 $ 728,700 $ 740,500
Cost of Goods 201,000 177,200 171,200 157,300
Gross Profit 650,100 566,500 557,500 583,200
Operating Expenses 642,500 444,800 513,700 430,100
Operating Income 7,600 121,900 44,000 153,400
Interest Expense 12,000 3,200 6,000 300
Other Income/Expenses 4,400 1,400 -1,800 2,900
Pre-tax Income - 120,100 36,200 156,000
Income Taxes -4,400 -13,000 19,000 38,800
Net Income from Cont. Operations 4,400 133,100 17,200 117,200
Minority Interest -200 -200 -200 -
Total Net Income $ 4,600 $ 133,300 $ 17,400 $ 117,200
Basic EPS from Cont. Ops. 0.06 1.92 0.25 1.67
Basic EPS from Total Ops. 0.06 1.92 0.25 1.67
Diluted EPS from Cont. Ops 0.06 1.85 0.25 1.60
Diluted EPS from Total Operations 0.06 1.85 0.25 1.60
EBITDA 80,600 176,300 92,300 180,200